Skip to content
Discover the latest technology trends, in-depth product rev…

The Zimbabwean Government Turns Down ‘One-Sided’ American Health Aid Package Because of Information Apprehensions

Health aid image
The proposed American funding was aimed at programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has declined a substantial American health deal valued at $367m (£272m) over five years over Washington's insistence on sensitive data.

This move was revealed after a internal memorandum from December was leaked, revealing that President Emmerson Mnangagwa deemed the deal was "skewed".

An official spokesman has since stated that the US was demanding access to biological samples for research and commercial purposes while refused to guarantee the resulting advantages from any future medical innovations.

"We will now turn to the challenging and unfortunate task of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has appealed for continued dialogue to secure a deal suitable to all parties so the country's vital HIV treatment initiative can proceed.

Wider Background

This development follows a similar case in Kenya, where a high court suspended a related deal with the US following concerns were raised about the safety of Kenyans' medical information.

Since returning to office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

The agency had overseen assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to boost transparency and accountability.

According to statements, 16 African countries have so far signed similar agreements, representing over $18.3bn of fresh investment.

Specifics of the Declined Agreement

This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this partnership could have provided significant advantages for Zimbabwean communities, especially the 1.2 million currently on antiretroviral therapy through American-funded programmes," Tremont added.

However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".

"The proposal required Zimbabwe to share its genetic material and health information indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.

"Put simply, our country would provide the raw materials for scientific discovery without any certainty that the final treatments would be available to our citizens if a future health crisis arise."

Sovereignty and Global Health

Mangwana further pointed out that the American exit from the global health body and its push of one-on-one deals were upending frameworks already established through the international health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential pandemics.

"This framework is designed to ensure that when a country provides its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.

"We are open to ongoing dialogue with our US partners on how future collaboration could be structured in a manner that honours the independence and interests of both nations."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but recommended that talks must proceed considering much of the country's HIV programmes relied on international support.

"If technical issues arise, including those relating to information security or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," the group said.

This impasse emphasises the ongoing debate between accepting much-needed foreign assistance and safeguarding a country's data in an ever more data-driven world.

Written by

Michael Brown

Elara is a tech journalist with a decade of experience covering cybersecurity and emerging technologies, passionate about making tech accessible.

Insider Net Site

Type to search articles.